Berkeley Lights, Inc. (BLI)
Market Cap | 5.39B |
Revenue (ttm) | 59.18M |
Net Income (ttm) | -32.92M |
Shares Out | 53.60M |
EPS (ttm) | -0.61 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | January 15 |
Last Price | $83.75 |
Previous Close | $83.75 |
Change ($) | 0.00 |
Change (%) | 0.00% |
Day's Open | 85.84 |
Day's Range | 82.65 - 90.09 |
Day's Volume | 1,415,165 |
52-Week Range | 56.00 - 106.00 |
EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto™ Plasma B Discovery 4.0 workflow. Opto Pla...
EMERYVILLE, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming 3...
Berkeley Lights (BLI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
EMERYVILLE, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its previously announced public offering of 3,000,...
EMERYVILLE, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the launch of a public offering of 3,000,000 shares of common sto...
Berkeley Lights, Inc. (BLI) CEO Eric Hobbs on Q3 2020 Results - Earnings Call Transcript
EMERYVILLE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended September 30...
EMERYVILLE, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be report financial results for th...
Eric Hobbs discusses how Berkeley Lights is not just fighting COVID-19, but also accelerating the design-build-test cycle for all of synthetic biology.
MIAOLI, Taiwan and EMERYVILLE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Mycenax Biotech, Inc. (4726.TWO), a pioneer of biopharmaceutical development in Taiwan, today announced its adoption...
EMERYVILLE, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcomin...
EMERYVILLE, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended June 30, 2...
EMERYVILLE, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., (Nasdaq: BLI) a leader in Digital Cell Biology, today announced the closing of its initial public offering of 9,3...
Shares of Berkeley Lights Inc. BLI, +134.09% took flight Friday, as the cell biology company went public at a price that was more than double what the upsized initial public offering was priced.
Berkeley Lights Inc. raised $178.2 million as the cell biology company's upsized initial public offering priced above the expected range.
About BLI
Berkeley Lights, a digital cell biology company that focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. It offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. The company was incorporated in 2011 and is based in Emeryville, California.
Industry Biotechnology | IPO Date Jul 17, 2020 |
CEO Eric Hobbs | Employees 210 |
Stock Exchange NASDAQ | Ticker Symbol BLI |
Financial Performance
In 2019, BLI's revenue was $56.69 million, an increase of 81.13% compared to the previous year's $31.30 million. Losses were -$18.30 million, -21.58% less than in 2018.
Analyst Forecasts
According to 5 analysts, the average rating for BLI stock is "Buy." The 12-month stock price forecast is 92.33, which is an increase of 10.24% from the latest price.